Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
After finishing at $22.87 in the prior trading day, Pfizer Inc (NYSE: PFE) closed at $22.02, down -3.72%. In other words, the price has decreased by -$3.72 from its previous closing price. On the day, 59.18 million shares were traded. PFE stock price reached its highest trading level at $22.9 during the session, while it also had its lowest trading level at $21.97.
Ratios:
Our goal is to gain a better understanding of PFE by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.23 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.16. For the most recent quarter (mrq), Quick Ratio is recorded 0.96 and its Current Ratio is at 1.26. In the meantime, Its Debt-to-Equity ratio is 0.69 whereas as Long-Term Debt/Eq ratio is at 0.64.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on April 22, 2025, initiated with a Neutral rating and assigned the stock a target price of $24.
On November 15, 2024, Wolfe Research started tracking the stock assigning a Underperform rating and target price of $25.Wolfe Research initiated its Underperform rating on November 15, 2024, with a $25 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 05 ’25 when Dolsten Mikael bought 55,000 shares for $23.87 per share.
DAMICO JENNIFER B. sold 2,500 shares of PFE for $64,825 on Mar 04 ’25. The SVP & Controller now owns 11,850 shares after completing the transaction at $25.93 per share. On Feb 13 ’25, another insider, BLAYLOCK RONALD E, who serves as the Director of the company, bought 19,457 shares for $25.65 each. As a result, the insider paid 499,072 and bolstered with 27,707 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PFE now has a Market Capitalization of 125191847936 and an Enterprise Value of 170568744960. As of this moment, Pfizer’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.96, and their Forward P/E ratio for the next fiscal year is 7.14. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.00 while its Price-to-Book (P/B) ratio in mrq is 1.39. Its current Enterprise Value per Revenue stands at 2.731 whereas that against EBITDA is 7.314.
Stock Price History:
The Beta on a monthly basis for PFE is 0.52, which has changed by -0.23858923 over the last 52 weeks, in comparison to a change of 0.11241627 over the same period for the S&P500. Over the past 52 weeks, PFE has reached a high of $31.54, while it has fallen to a 52-week low of $20.92. The 50-Day Moving Average of the stock is -8.45%, while the 200-Day Moving Average is calculated to be -17.40%.
Shares Statistics:
The stock has traded on average 53.77M shares per day over the past 3-months and 51123190 shares per day over the last 10 days, according to various share statistics. A total of 5.68B shares are outstanding, with a floating share count of 5.68B. Insiders hold about 0.06% of the company’s shares, while institutions hold 65.95% stake in the company. Shares short for PFE as of 1745971200 were 115162479 with a Short Ratio of 2.14, compared to 1743379200 on 97494423. Therefore, it implies a Short% of Shares Outstanding of 115162479 and a Short% of Float of 2.0299999.
Dividends & Splits
In the trailing 12 months, PFE’s forward annual dividend rate was 1.69, compared to 1.70 this year. Against a Trailing Annual Dividend Yield of 0.07389593The stock’s 5-year Average Dividend Yield is 4.48. The current Payout Ratio is 119.94% for PFE, which recently paid a dividend on 2025-05-09 with an ex-dividend date of 1746748800. Stock splits for the company last occurred on 2020-11-17 when the company split stock in a 1054:1000 ratio.
